Back to transactions
Food & Beverage

Kan Biosys Acquired by De Sangosse

Date
March 2023
Transaction Type
Strategic acquisition
Value
Undisclosed
Acquired by
Company brand product
Company brand product
Company brand product
Company brand product
Company brand product
Back to transactions
Food & Beverage

Kan Biosys Acquired by De Sangosse

Date
March 2023
Transaction Type
Strategic acquisition
Value
Undisclosed
Acquired by
Company brand product
Company brand product
Company brand product
Company brand product
Company brand product

Transaction
Overview

Spayne Lindsay & Co LLP is delighted to announce that it has advised De Sangosse, an international player in crop protection, plant nutrition and pest control, on its strategic alliance with Kan Biosys, an established player in microbial technologies in India.

The goal of the strategic alliance is to build a robust microbial and bio-solutions ecosystem in India by delivering high-quality biological products that improve the quality and quantity of crop yield.

Kan Biosys operates in seven states and exports products to seven countries. The company’s DNA is centered around innovation, evident from its track record of achievements. Kan Biosys began its journey by obtaining the first Indian patent for liquid biofertilizers for nitrogen-fixing bacteria, which was recognized with the first Technology Day award and WIPO gold medal of the United Nations. Since then, the company has collaborated with over a million farmers in India and established a reputation as a leading player in the industry, with numerous firsts to its credit, such as Milastin (first registered bio-fungicide based on Bacillus subtilis KTSB 1015 was registered for control of powdery mildew in grapes).

“With over 160 million arable hectares, India represents a significant market for our group. Both companies will work together to leverage their research capabilities to develop new products that support global agricultural trends and Indian farmers. Our aim is to provide innovative and sustainable solutions in agriculture that will benefit our customers in the Indian market by developing synergies between DE SANGOSSE and Kan Biosys. We are excited to collaborate with an experienced and dedicated team to expand Kan Biosys’ business. We believe the high-quality portfolio of Kan Biosys’ microbial products and its strong presence in India will enhance our global projects.”

Nicolas Fillon
CEO DE SANGOSSE
Our Recent Transactions

Our deep industry knowledge, global perspective and strong relationships make us a trusted advisor to leading consumer companies and investors

See more

Contact Spayne Lindsay for further information

Contact us